$MBRX News Article - Moleculin Reports 80% Overall
Post# of 62
(Total Views: 201)
Posted On: 12/15/2022 10:30:46 AM
$MBRX News Article - Moleculin Reports 80% Overall Response Rate in Final Cohort of Phase 1 Single Agent Trial of Annamycin for the Treatment of Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/mole...98024.html
(0)
(0)Moleculin Biotech, Inc. (MBRX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼